跳至主要内容
临床试验/NCT01023022
NCT01023022已完成不适用

Medtronic CareLink® Network Evaluation Protocol

Medtronic Cardiac Rhythm and Heart Failure10 个研究点 分布在 1 个国家目标入组 176 人开始时间: 2010年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
176
试验地点
10
主要终点
Comparison of Remote Device Check and In-clinic Device Assessment

研究概览

简要总结

The purpose of the study is to demonstrate the value of the Medtronic CareLink® Network in clinical practice in the country specific healthcare setting.

详细描述

Evaluation's objectives:

Comparison of remote device check and in-clinic device assessment. To assess patient ease of use of, and satisfaction with, the Medtronic CareLink® Monitor To assess clinician ease of use of, and satisfaction with, the Medtronic CareLink® Monitor and Website To assess the clinic specific clinical value of Medtronic CareLink® Network Demonstrate time savings for patients Demonstrate time savings for physicians To show the increase of efficiency through increased flexibility and per procedure time To demonstrate better handling of unscheduled activities (symptoms, events, etc.)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Patients who have an implanted Medtronic ICD, CRT-D device that is supported by the Medtronic CareLink® Network
  • •Patients have to sign the Medtronic CareLink® "Statement of Privacy Principles" and the "Evaluation Data Protection Statement" documents

排除标准

  • •Patients with exclusion criteria required by local law
  • •Patient is anticipated to demonstrate poor compliance (for example, mental disturbances)

结局指标

主要结局

Comparison of Remote Device Check and In-clinic Device Assessment

时间窗: Baseline to max. 12 months

"Investigators were asked the following question: how did the Medtronic CareLink system matched their personal expectation/goals and had to answer with multiple answer using the following ranking Significantly exceeded, Goals met, No expectations, Not met, Not met at all: Question 1) Newest technology for my patients. Q2) Increased patient safety. Q3) Increased patient satisfaction. Q4) Improved quality of life for my patients. Q5) Improved follow up after therapy/shock delivery of for symptomatic patients, adverse events. Q6) Increased hospital efficiency. Q7) Increased follow up quality. Q8) More flexible follow up schemes possible. Q9) Better management of the increased number of follow ups. Q10) Increased satisfaction of hospital personnel. Q11) Other goals"

次要结局

  • Efficiency Through Increased Flexibility and Per Procedure Time(Baseline to max. 12 months)
  • Patient Ease of Use of, and Satisfaction With the Medtronic CareLink® Monitor (Including Percentage of Patients Who Prefer Follow up With Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up)(Baseline to max. 12 months)
  • Clinic-specific Clinical Value of Medtronic CareLink® Network (Change of Workflow, Increase of Flexibility)(Baseline to max. 12 months)
  • Time and Cost Savings for Patients(Baseline to max. 12 months)
  • Clinician Ease of Use of, and Satisfaction With, the Medtronic CareLink® Monitor and Website (Including Clinician General Preference, if Any, for Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up)(Baseline to max. 12 months)
  • Time and Costs Savings for Physicians(Baseline to max. 12 months)
  • Handling of Unscheduled Activities (for Example, Symptoms and Events)(Baseline to max. 12 months)

研究者

发起方
Medtronic Cardiac Rhythm and Heart Failure
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验